WAY-208466

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameWAY-208466
Drug Alias NameWAY-208466
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsObsessive-Compulsive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsObsessive-Compulsive Disorder

Other Information

ATC CodeN/A
Related LinksN/A